Skip to content
2000
Volume 7, Issue 3
  • ISSN: 1573-3971
  • E-ISSN: 1875-6360

Abstract

Rheumatoid arthritis (RA) is an autoimmune disease that causes chronic inflammation of the joints. It is associated with increased mortality rates as compared to the healthy population. The actual cause of rheumatoid arthritis is unknown although several factors accelerating its progression are outlined. This review enlists various histopathological changes and encompasses a note on its applicability in target specific delivery with the aid of antibodies. There are various first-line, second-line and newer biological treatments available. This review gives brief detail of the novel approaches for the delivery of the targeted as well as non targeted systems like oral, topical, nasal and parenteral and the recent advancements that have been achieved. Moreover, it also gives an account of the amendment that can be made for future with the use of biotechnology, the application of gene profiling and gene array techniques.

Loading

Article metrics loading...

/content/journals/crr/10.2174/157339711796320547
2011-08-01
2025-05-18
Loading full text...

Full text loading...

/content/journals/crr/10.2174/157339711796320547
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test